This report provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death.
This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into:
- Unit volumes from 2020 to 2026
- Market forecasts from 2020 to 2026
- Competitive landscape analysis of major competitors
- Insights into key market events for strategics and startups
Companies Mentioned
- ArtVentive Medical
- Boston Scientific
- Embolx
- Fluidx Medical Technology
- Instylla
- Merit Medical
- Sirtex Medical
- Stryker
- Terumo
